Ganciclovir Injection Clinical Trials

• Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
  ClinicalTrials.gov Identifier: NCT00000143 - Active, not recruiting
  Cytomegalovirus Retinitis; HIV Infections
  
• Kinetics of response of cytomegalovirus with ganciclovir treatment using quantitative real-time PCR
  ClinicalTrials.gov Identifier: NCT00004573 - Active, not recruiting
  Cytomegalovirus Infections
  
• A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis
  ClinicalTrials.gov Identifier: NCT00000698 - Active, not recruiting
  Cytomegalovirus Retinitis; HIV Infections
  
• A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease
  ClinicalTrials.gov Identifier: NCT00000805 - Active, not recruiting
  Cytomegalovirus Infections; HIV Infections
  
• The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients with HIV
  ClinicalTrials.gov Identifier: NCT00001034 - Active, not recruiting
  Cytomegalovirus Retinitis; HIV Infections; Gastrointestinal Diseases
  
• A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People with AIDS Who Have Received Prior Ganciclovir Therapy
  ClinicalTrials.gov Identifier: NCT00002247 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients
  ClinicalTrials.gov Identifier: NCT00000768 - Completed
  Colitis; HIV Infections
  
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
  Ovarian Neoplasms
  
• Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma
  ClinicalTrials.gov Identifier: NCT00006216 - Active, not recruiting
  recurrent malignant mesothelioma; advanced malignant mesothelioma; localized malignant mesothelioma; childhood thorax/respiratory cancer
  
• A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )
  ClinicalTrials.gov Identifier: NCT00002156 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis
  ClinicalTrials.gov Identifier: NCT00002134 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients with AIDS Who Have Already Been Treated with Ganciclovir
  ClinicalTrials.gov Identifier: NCT00000970 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS
  ClinicalTrials.gov Identifier: NCT00001999 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00431353 - Active, not recruiting
  Cytomegalovirus Infections
  
• Follow-Up Assessment of Subjects Who Received Ganciclovir for CMV Infections
  ClinicalTrials.gov Identifier: NCT00031421 - Active, not recruiting
  Cytomegalovirus Infections
  
• Penile Injection Anxiety
  ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
  Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
  
• Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant
  ClinicalTrials.gov Identifier: NCT00530218 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00016068 - Active, not recruiting
  Infection
  
• Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma
  ClinicalTrials.gov Identifier: NCT00093704 - Recruiting
  recurrent adult Hodgkin's lymphoma; recurrent adult Burkitt's lymphoma; post-transplant lymphoproliferative disorder; ...
  
• Pediatric Kidney Transplant without Calcineurin Inhibitors
  ClinicalTrials.gov Identifier: NCT00023231 - Active, not recruiting
  End-Stage Renal Disease
  
• Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
  ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
  Myocardial Infarction
  
• Gene Therapy for the Treatment of Brain Tumors
  ClinicalTrials.gov Identifier: NCT00001328 - Active, not recruiting
  Brain Neoplasm; Neoplasm Metastasis
  
• Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00497796 - Recruiting
  Cytomegalovirus Infections
  
• Assessment of valganciclovir in neonates with CMV
  ClinicalTrials.gov Identifier: NCT00031434 - Active, not recruiting
  Cytomegalovirus Infections
  
• A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
  Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism
  
• A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients with AIDS
  ClinicalTrials.gov Identifier: NCT00002273 - Completed
  Colitis; HIV Infections
  
• Islet Cell Transplants for Diabetes
  ClinicalTrials.gov Identifier: NCT00014911 - Active, not recruiting
  Diabetes Mellitus, Insulin-Dependent
  
• A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients with AIDS Who Have Not Had Success with Ganciclovir
  ClinicalTrials.gov Identifier: NCT00002301 - Active, not recruiting
  Cytomegalovirus Retinitis; HIV Infections
  
• A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus
  ClinicalTrials.gov Identifier: NCT00002095 - Completed
  Cytomegalovirus Infections; HIV Infections
  
• A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir
  ClinicalTrials.gov Identifier: NCT00002251 - Completed
  Cytomegalovirus Infections; HIV Infections
  
• Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00035867 - Active, not recruiting
  Myelodysplastic Syndromes
  
• An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access
  ClinicalTrials.gov Identifier: NCT00002135 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• The Safety and Effectiveness of Ganciclovir Used Alone or in Combination with Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients with AIDS
  ClinicalTrials.gov Identifier: NCT00000989 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children
  ClinicalTrials.gov Identifier: NCT00002015 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.
  ClinicalTrials.gov Identifier: NCT00001100 - Completed
  Cytomegalovirus Infections
  
• A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment with Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People with AIDS
  ClinicalTrials.gov Identifier: NCT00002257 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Study of the Safety and Tolerance of Long-Term Therapy with Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons with AIDS
  ClinicalTrials.gov Identifier: NCT00002034 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients with AIDS
  ClinicalTrials.gov Identifier: NCT00002330 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS
  ClinicalTrials.gov Identifier: NCT00000688 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
  ClinicalTrials.gov Identifier: NCT00548197 - Recruiting
  Intravitreal Bevacizumab Injection; Pars Plana Vitrectomy; Tractional Retinal Detachment; Diabetic Retinopathy
  
• A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir
  ClinicalTrials.gov Identifier: NCT00000668 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Adverse Drug Reactions of Different Brands of Ceftazidime Injection
  ClinicalTrials.gov Identifier: NCT00173901 - Active, not recruiting
  Infection
  
• Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)
  ClinicalTrials.gov Identifier: NCT00000136 - Completed
  HIV Infections; Cytomegalovirus Retinitis
  
• Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection
  ClinicalTrials.gov Identifier: NCT00004278 - Completed
  Cytomegalovirus Infections
  
• A Study of AZT Plus Ganciclovir in Patients with AIDS and Cytomegalovirus (CMV) Infection
  ClinicalTrials.gov Identifier: NCT00000995 - Completed
  Cytomegalovirus Infections; HIV Infections
  
• Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients with AIDS Who Have CMV Retinitis
  ClinicalTrials.gov Identifier: NCT00000894 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component
  ClinicalTrials.gov Identifier: NCT00000665 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Topical Amethocaine Gel for Intramuscular Injection in Term Neonates
  ClinicalTrials.gov Identifier: NCT00267111 - Active, not recruiting
  Pain
  
• Validation of Self-Reported Needle Sharing Among Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00341081 - Active, not recruiting
  Viral Infection
  
• EPC by Intracoronary Injection in Patients With Chronic Stable Angina
  ClinicalTrials.gov Identifier: NCT00384514 - Active, not recruiting
  Coronary Artery Disease
  
• A Effectiveness and Safety Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy
  ClinicalTrials.gov Identifier: NCT00125424 - Active, not recruiting
  Colonoscopy; Colon Polyps; Endoscopic sedation; Endoscopic outcomes; Endoscopy
  
• A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy
  ClinicalTrials.gov Identifier: NCT00000673 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes
  ClinicalTrials.gov Identifier: NCT00002377 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients with AIDS
  ClinicalTrials.gov Identifier: NCT00002299 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
  ClinicalTrials.gov Identifier: NCT00529165 - Recruiting
  Diabetes Mellitus Type 2; Injection to Meal Time; Human Insulin
  
• A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes
  ClinicalTrials.gov Identifier: NCT00001062 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00006480 - Active, not recruiting
  disseminated neuroblastoma; Drug Toxicity; recurrent neuroblastoma
  
• Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient
  ClinicalTrials.gov Identifier: NCT00002025 - Completed
  Cytomegalovirus Infections; Cytomegalovirus Retinitis; HIV Infections
  
• Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00005025 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
  
• Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow
  ClinicalTrials.gov Identifier: NCT00395616 - Recruiting
  Type A Botulinum Toxin; Tennis Elbow
  
• Kidney Transplants in People with HIV Infection
  ClinicalTrials.gov Identifier: NCT00023478 - Active, not recruiting
  HIV Infections; End-Stage Renal Disease
  
• Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial
  ClinicalTrials.gov Identifier: NCT00375817 - Active, not recruiting
  Myocardial Infarction; Heart Failure, Congestive
  
• Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00192517 - Active, not recruiting
  Psoriasis
  
• A 2-Year Study of Patients With Schizophrenia Who Are Treated With Long-Acting Risperidone Injection.
  ClinicalTrials.gov Identifier: NCT00246194 - Active, not recruiting
  Schizophrenia
  
• IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients
  ClinicalTrials.gov Identifier: NCT00533962 - Active, not recruiting
  Glaucoma; Intraocular Pressure
  
• Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00164372 - Active, not recruiting
  HIV Infections; Hepatitis C
  
• Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection
  ClinicalTrials.gov Identifier: NCT00491712 - Active, not recruiting
  Neovascular Glaucoma
  
• A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
  ClinicalTrials.gov Identifier: NCT00218192 - Active, not recruiting
  HCV Negative Status; HCV Risk Behavior
  
• A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
  ClinicalTrials.gov Identifier: NCT00225095 - Active, not recruiting
  Recovery Following Partial Medial Meniscectomy
  
• Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis
  ClinicalTrials.gov Identifier: NCT00002070 - Completed
  Cytomegalovirus Retinitis; HIV Infections
  
• Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00361842 - Active, not recruiting
  Colorectal Neoplasms
  
• Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections
  ClinicalTrials.gov Identifier: NCT00002024 - Completed
  Cytomegalovirus Infections; HIV Infections
  
• A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine
  ClinicalTrials.gov Identifier: NCT00002096 - Completed
  Cytomegalovirus Infections; HIV Infections
  
• Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00193037 - Active, not recruiting
  Breast Cancer
  
• Vitamin K Injections for the Treatment of Painful Menstruation
  ClinicalTrials.gov Identifier: NCT00104546 - Active, not recruiting
  Dysmenorrhea
  
• Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
  ClinicalTrials.gov Identifier: NCT00580060 - Active, not recruiting
  Melanoma
  
• Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00004740 - Active, not recruiting
  Tuberculosis
  
• Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads
  ClinicalTrials.gov Identifier: NCT00054951 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
  ClinicalTrials.gov Identifier: NCT00446082 - Active, not recruiting
  Carcinoid Tumor; Acromegaly
  
• Patients Preference With Self-Injection: The PRISM Study
  ClinicalTrials.gov Identifier: NCT00253396 - Recruiting
  Bruises
  
• Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting
  ClinicalTrials.gov Identifier: NCT00076648 - Active, not recruiting
  Hemorrhagic Shock
  
• Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00344968 - Active, not recruiting
  Diabetic Macular Edema
  
• Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00394030 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Study of Taxoprexin Injection vs. Dacarbazine in Patients with Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00087776 - Active, not recruiting
  Malignant Melanoma
  
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control
  ClinicalTrials.gov Identifier: NCT00283049 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Study of TPI 287 in Patients with Advanced Malignancies
  ClinicalTrials.gov Identifier: NCT00113724 - Active, not recruiting
  Neoplasms
  
• A Study to Determine the Effectiveness and Safety of Risperidone in the Prevention of Bipolar Mood Episodes
  ClinicalTrials.gov Identifier: NCT00132678 - Active, not recruiting
  Bipolar Disorder
  
• Azithromycin/Bicillin for treatment of early syphilis
  ClinicalTrials.gov Identifier: NCT00031499 - Active, not recruiting
  Syphilis
  
• Treating High Risk Leukemia with CD40 Ligand & IL-2 Gene Modified Tumor Vaccine.
  ClinicalTrials.gov Identifier: NCT00058799 - Active, not recruiting
  Leukemia
  
• Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab
  ClinicalTrials.gov Identifier: NCT00417703 - Recruiting
  Choroidal Neovascularization
  
• Botulinum Toxin Injection for the Management of BPH
  ClinicalTrials.gov Identifier: NCT00451191 - Recruiting
  Benign Prostatic Hyperplasia
  
• Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis
  ClinicalTrials.gov Identifier: NCT00497913 - Recruiting
  Tennis Elbow
  
• A Phase 2 open-label clinical study using intravenous Paxceed™ to treat patients with rheumatoid arthritis
  ClinicalTrials.gov Identifier: NCT00055133 - Active, not recruiting
  Rheumatoid Arthritis
  
• ATX-101 (Sodium Deoxycholate for Injection) for the Treatment of Superficial Lipomas
  ClinicalTrials.gov Identifier: NCT00422188 - Recruiting
  Lipoma
  
• The ORIGIN Trial (Outcome Reduction with Initial Glargine Intervention)
  ClinicalTrials.gov Identifier: NCT00069784 - Active, not recruiting
  Diabetes Mellitus, Non-Insulin-Dependent
  
• Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma
  ClinicalTrials.gov Identifier: NCT00307606 - Recruiting
  Breast Neoplasms; Mastectomy
  
• To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients when given with an Experimental Injection Catheter
  ClinicalTrials.gov Identifier: NCT00090714 - Active, not recruiting
  Angina Pectoris
  
• Safety and Effectiveness of SeeMore (EVP 1001-1 Injection) for MRI in Heart Patients
  ClinicalTrials.gov Identifier: NCT00340925 - Recruiting
  Myocardial Infarction
  
• Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation
  ClinicalTrials.gov Identifier: NCT00575744 - Recruiting
  Breast Cancer
  
• An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00229658 - Active, not recruiting
  Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus